Genetic Signatures advances revised Microba merger to AGM vote

• New ASX Listing Rule 7.1 approval required for the Microba scheme securities issue
• Microba shareholders would own 60% of the enlarged GSS, with existing GSS holders retaining 40%
• Up to 340.7 million GSS shares and 129.7 million GSS options proposed
• Microba placement reduces the indicative option ratio from 0.475 to 0.444 per Microba security